High Tide Inc. (TSXV: HITI)
Health Care · Pharmaceuticals · CA
CA$3.75
+1.90% today · -25.1% 1Y
High Tide Inc. (TSXV: HITI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $234.28M and employs 1,832 people.
Over the last twelve months the share price has lost 25.1%, trading between 2.86 and 5.06.
Tweenvest scores High Tide Inc. across four factors: quality 57/100, value 58/100, growth 100/100. Its strongest factor is growth.
HITI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $234.28M
- Revenue (TTM)
- $513.57M
- P/E
- —
- EPS
- -0.39
- Dividend yield
- —
- Beta (5Y)
- 0.95
- 52-week high
- CA$5.06
- 52-week low
- CA$2.86
- Avg volume (3M)
- —
- Shares outstanding
- 89.14M
- Employees
- 1,832
- Next earnings
- —
About High Tide Inc.
High Tide Inc. operates as a prominent global player in the cannabis retail sector, with business activities spanning Canada, Europe, the United States, and other international markets. The company's portfolio is multifaceted, including the design, manufacturing, and distribution of various smoking accessories and cannabis-inspired lifestyle products. Beyond merchandise, High Tide is actively involved in the wholesale and direct retail of cannabis products, managing and franchising numerous licensed cannabis dispensaries. Furthermore, it offers data analytics services and runs the online retail platforms Grasscity.com and CBDcity.com. As of October 25, 2022, High Tide maintained a substantial retail presence with 149 locations throughout several Canadian provinces, including Ontario, Alberta, British Columbia, Manitoba, and Saskatchewan. Founded in 2009, this Calgary, Canada-based company was rebranded as High Tide Inc. in October 2018, having previously operated under the name High Tide Ventures Inc.
- ISIN
- CA42981E4013
- Founded
- 2009
- Listed since
- Dec 17, 2018
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cresco Labs Inc.CNSX: CL | $239.19M | CA$0.92 | -3.16% |
| SIGA Technologies, Inc.NasdaqGM: SIGA | $235.67M | $3.17 | -3.51% |
| Daito Pharmaceutical Co.,Ltd.TSE: 4577 | $235.23M | ¥1,318.00 | +0.69% |
| Sol-Gel Technologies Ltd.NasdaqCM: SLGL | $234.97M | $72.70 | +1.30% |
| Sakar Healthcare LimitedNSEI: SAKAR | $232.54M | Rs1,011.50 | -5.91% |
| Savior Lifetec CorporationTPEX: 4167 | $228.12M | NT$22.00 | +12.53% |
| Syncom Formulations (India) LimitedBSE: 524470 | $225.92M | Rs23.26 | -2.96% |
| Sai Parenteral's LimitedNSEI: SAIPARENT | $225.46M | Rs493.90 | -5.68% |
Figures last refreshed Oct 11, 2026.